- Home
- FHTX vs MVF Comparison
FHTX vs MVF Comparison
Compare FHTX & MVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- MVF
- Stock Information
- Founded
- FHTX 2015
- MVF 1988
- Country
- FHTX United States
- MVF United States
- Employees
- FHTX N/A
- MVF N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- MVF Investment Bankers/Brokers/Service
- Sector
- FHTX Health Care
- MVF Finance
- Exchange
- FHTX Nasdaq
- MVF Nasdaq
- Market Cap
- FHTX 513.7M
- MVF 465.2M
- IPO Year
- FHTX 2020
- MVF N/A
- Fundamental
- Price
- FHTX $5.14
- MVF $7.06
- Analyst Decision
- FHTX Strong Buy
- MVF
- Analyst Count
- FHTX 5
- MVF 0
- Target Price
- FHTX $13.80
- MVF N/A
- AVG Volume (30 Days)
- FHTX 197.3K
- MVF 162.8K
- Earning Date
- FHTX 11-04-2024
- MVF 01-01-0001
- Dividend Yield
- FHTX N/A
- MVF 4.11%
- EPS Growth
- FHTX N/A
- MVF N/A
- EPS
- FHTX N/A
- MVF N/A
- Revenue
- FHTX $25,515,000.00
- MVF N/A
- Revenue This Year
- FHTX N/A
- MVF N/A
- Revenue Next Year
- FHTX $11.54
- MVF N/A
- P/E Ratio
- FHTX N/A
- MVF N/A
- Revenue Growth
- FHTX N/A
- MVF N/A
- 52 Week Low
- FHTX $2.70
- MVF $5.85
- 52 Week High
- FHTX $10.25
- MVF $7.19
- Technical
- Relative Strength Index (RSI)
- FHTX 27.35
- MVF 26.96
- Support Level
- FHTX $4.69
- MVF $7.37
- Resistance Level
- FHTX $5.70
- MVF $7.43
- Average True Range (ATR)
- FHTX 0.61
- MVF 0.08
- MACD
- FHTX -0.14
- MVF -0.04
- Stochastic Oscillator
- FHTX 16.24
- MVF 13.71
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About MVF Blackrock MuniVest Fund Inc.
Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.